Bufexamac is a hydroxamic acid derived from phenylacetamide in which the benzene moiety is substituted at C-4 by a butoxy group. It has anti-inflammatory, analgesic, and antipyretic properties. Among its listed roles, it functions as a non-narcotic analgesic, a non-steroidal anti-inflammatory drug and an antipyretic. It is grouped under the following drug class(es): Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics and antirheumatic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Parfenac, Bufexamic acid and Anderm. Its PubChem CID is 2466.
Bufexamac
| CAS No | 2438-72-4 |
|---|---|
| Molecular Formula | C12H17NO3 |
| Molecular Weight | 223.27 g/mol |
| Synonyms | 2-(4-butoxyphenyl)-N-hydroxyacetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bufexamac is a hydroxamic acid derived from phenylacetamide in which the benzene moiety is substituted at C-4 by a butoxy group. It has anti-inflammatory, analgesic, and antipyretic properties.
The listed CAS number is 2438-72-4.
The listed molecular formula is C12H17NO3.
The listed molecular weight is 223.27 g/mol.
2-(4-butoxyphenyl)-N-hydroxyacetamide.
The source lists Parfenac, Bufexamic acid and Anderm.